Biocept Shares Up on Planned Start of Covid-19 Testing
April 09 2020 - 8:17PM
Dow Jones News
By Josh Beckerman
Shares of Biocept Inc., which provides liquid biopsy tests for
cancer patients, rose 12% to 40 cents after hours as the company
said it will conduct Covid-19 testing.
Biocept said it has verified a molecular diagnostic test, and
plans to begin accepting physician-ordered testing requests for
processing beginning April 15.
Biocept's lab will use Thermo Fisher Scientific Inc.'s TaqPath
platform and kit.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
April 09, 2020 20:02 ET (00:02 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Apr 2023 to Apr 2024